ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2032

Goal Concordance in Rheumatoid Arthritis Patients with Depression – What Do Patients Prioritize?

Allison Schue1, Rachel Matsumoto2 and Jennifer Barton3, 1Providence St. Vincent Medical Center, Portland, OR, 2VA Portland Health Care System, Portland, OR, 3VA Portland Health Care System/OHSU, Portland, OR

Meeting: ACR Convergence 2023

Keywords: rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2019–2038) Patient Outcomes, Preferences, & Attitudes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Depression prevalence in patients with rheumatoid arthritis (RA) is higher than the general population (~40% and 4.1%, respectively). Patients with depressive symptoms show reduced biologic therapy response. Patient-clinician goal concordance has been linked to improved outcomes in other chronic conditions including diabetes but has not been explored in RA patients with depression. Our objective was to (a) describe treatment goals for RA patients with and without depression and (b) assess whether RA patient-clinician goal concordance varies by depression status.

Methods: RA patients seen in the prior 12 months at one of two rheumatology clinics (Veterans Affairs- and university-based) were enrolled in a cross-sectional survey study. Patients and their rheumatology clinician independently ranked their top three (of eight) RA treatment goals. PHQ8 score ≥10 defined depression. Descriptive statistics were used to characterize treatment goals for both groups. Fisher’s exact test was used to determine statistical significance with a Bonferroni correction to account for multiple comparisons (p= 0.006). Goal concordance, defined as a patient’s top goal ranked in their clinician’s top three goals, was compared between groups.

Results: 148 dyads were included in the analysis (148 patients, 14 clinicians). Patients were 51% female and 28% non-white, with mean disease duration of 12 years (SD= 9). 32 patients (22%) met depression criteria. Overall, “less pain” was identified as a treatment goal most often, regardless of depression status (81% depressed, 91% non-depressed, p= 0.21). Similarly, “fewer problems doing my daily activities” was the second-most selected treatment priority for patients with and without depression (56% and 69%, respectively, p= 0.21). However, patients with depression identified “feel less tired” as their third-most selected goal (47% depressed, 33% non-depressed, p=0.15), while those without depression identified “avoid side effects from medication” third-most frequently (41% non-depressed, 28% depressed, p=0.22). Patients with depression also identified “improve sleep” as a goal more often than patients without depression (41% depressed, 16% non-depressed, p= 0.006). Goal concordance did not differ significantly between patients with and without depression (91% and 78% meeting concordance definition, respectively, p= 0.1).

Conclusion: RA patients, regardless of concomitant depressed mood, most often prioritized “less pain,” followed by “fewer problems doing my daily activities.” However, differences emerged in the third-most valued goal such that patients with depression ranked “feel less tired” and patients without depression ranked “avoid side effects from medication” more often. Goal concordance did not differ significantly between groups, which may be explained by the high value placed on pain in goal ranking and our patient-centered definition of concordance. Pain is a common symptom in RA and routinely elicited at clinic visits, prompting discussions between patients and clinicians. Research to explore ways to improve goal elicitation beyond pain among all RA patients and their clinicians is warranted.


Disclosures: A. Schue: None; R. Matsumoto: None; J. Barton: None.

To cite this abstract in AMA style:

Schue A, Matsumoto R, Barton J. Goal Concordance in Rheumatoid Arthritis Patients with Depression – What Do Patients Prioritize? [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/goal-concordance-in-rheumatoid-arthritis-patients-with-depression-what-do-patients-prioritize/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/goal-concordance-in-rheumatoid-arthritis-patients-with-depression-what-do-patients-prioritize/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology